Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
Fujita Medical Journal · 2023-05 · 9 (2) · 80-83
DOI: 10.20407/fmj.2021-027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fujita Medical Journal, 2023-05. Verfasst von Masakazu Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Objectives
We conducted an analysis of first-time tolvaptan users (≥80 years old) to determine the factors associated with the prognosis of elderly patients with heart failure.
Methods
We retrospectively analyzed 66 consecutive patients with worsening heart failure (aged ≥80 years) who were admitted to Fujita Health University Bantane Hospital from 2011 to 2016 and treated with tolvaptan. Differences between the in-hospital death and survival groups were evaluated. Multivariate logistic regression analysis was also performed to identify the risk factors for mortality.
Results
Sixty-six patients were included, and 26 patients died during the index hospitalization. The patients who died had a significantly higher prevalence of ischemic heart disease; a higher heart rate; higher levels of plasma C-reactive protein, blood urea nitrogen (BUN), and creatinine; a lower serum albumin level; and a lower estimated glomerular filtration rate than surviving patients. The proportion of patients requiring early initiation of tolvaptan treatment (within 3 days of admission) was significantly higher in surviving patients. On the basis of multivariate logistic regression analysis, although a high heart rate and high BUN levels were independent factors for in-hospital prognosis, they were not significantly associated with the early use of tolvaptan (≤3 days vs. ≥4 days; odds ratio=0.39; 95% confidence interval=0.07–2.21; p=0.29).
Conclusions
This study revealed that a higher heart rate and higher BUN levels were independent factors for in-hospital prognosis in elderly patients who received tolvaptan and that early tolvaptan use may not always be effective in elderly patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan.
- Department of Cardiology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
- Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
Zitieren
APA
Kobayashi, M., Hayashi, M., Yamada, R., Ishiguro, T., Fujiwara, W., Ishii, H., Naruse, H., Watanabe, E., Ozaki, Y., & Izawa, H. (2023). Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan. Fujita Medical Journal, 9(2), 80-83. https://doi.org/10.20407/fmj.2021-027
Vancouver
Kobayashi M, Hayashi M, Yamada R, Ishiguro T, Fujiwara W, Ishii H, et al. Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan. Fujita Medical Journal. 2023;9(2):80-83. doi:10.20407/fmj.2021-027
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Masakazu and Hayashi, Mutsuharu and Yamada, Ryo and Ishiguro, Tomoya and Fujiwara, Wakaya and Ishii, Hideki and Naruse, Hiroyuki and Watanabe, Eiichi and Ozaki, Yukio and Izawa, Hideo},
title = {Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan},
journal = {Fujita Medical Journal},
year = {2023},
volume = {9},
number = {2},
pages = {80--83},
doi = {10.20407/fmj.2021-027}
}
EUVIMED